JP2025505644A5 - - Google Patents

Info

Publication number
JP2025505644A5
JP2025505644A5 JP2024546422A JP2024546422A JP2025505644A5 JP 2025505644 A5 JP2025505644 A5 JP 2025505644A5 JP 2024546422 A JP2024546422 A JP 2024546422A JP 2024546422 A JP2024546422 A JP 2024546422A JP 2025505644 A5 JP2025505644 A5 JP 2025505644A5
Authority
JP
Japan
Prior art keywords
groups
optionally substituted
alkyl
independently selected
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024546422A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025505644A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/012578 external-priority patent/WO2023154309A1/en
Publication of JP2025505644A publication Critical patent/JP2025505644A/ja
Publication of JP2025505644A5 publication Critical patent/JP2025505644A5/ja
Pending legal-status Critical Current

Links

JP2024546422A 2022-02-08 2023-02-08 Apol1の阻害剤としての4’,5’-ジヒドロスピロ[ピペリジン-4,7’-チエノ[2,3-c]ピラン]誘導体、及びそれを使用する方法 Pending JP2025505644A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263307876P 2022-02-08 2022-02-08
US63/307,876 2022-02-08
PCT/US2023/012578 WO2023154309A1 (en) 2022-02-08 2023-02-08 4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using same

Publications (2)

Publication Number Publication Date
JP2025505644A JP2025505644A (ja) 2025-02-28
JP2025505644A5 true JP2025505644A5 (cg-RX-API-DMAC7.html) 2026-02-04

Family

ID=85685675

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024546422A Pending JP2025505644A (ja) 2022-02-08 2023-02-08 Apol1の阻害剤としての4’,5’-ジヒドロスピロ[ピペリジン-4,7’-チエノ[2,3-c]ピラン]誘導体、及びそれを使用する方法

Country Status (7)

Country Link
US (1) US20250136612A1 (cg-RX-API-DMAC7.html)
EP (1) EP4476228A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025505644A (cg-RX-API-DMAC7.html)
CN (1) CN119013281A (cg-RX-API-DMAC7.html)
AU (1) AU2023218939A1 (cg-RX-API-DMAC7.html)
CA (1) CA3251124A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023154309A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3897833T (lt) 2018-12-17 2026-04-27 Vertex Pharmaceuticals Incorporated Apol1 inhibitoriai ir jų panaudojimo būdai
EP4097083A1 (en) 2020-01-29 2022-12-07 Vertex Pharmaceuticals Incorporated Inhibitors of apol1 and methods of using same
EP4146633A4 (en) 2020-05-07 2024-09-25 Rambam Med-Tech Ltd. COMPOSITION FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH APOL1
JP2023530271A (ja) 2020-06-12 2023-07-14 バーテックス ファーマシューティカルズ インコーポレイテッド Apol1の阻害剤及びこれを使用する方法
CN115867543A (zh) 2020-06-12 2023-03-28 弗特克斯药品有限公司 Apol1抑制剂的固体形式及其使用方法
BR112023003423A2 (pt) 2020-08-26 2023-03-21 Vertex Pharma Inibidores de apol1 e métodos de uso destes
US12612379B2 (en) 2021-11-30 2026-04-28 Vertex Pharmaceuticals Incorporated Inhibitors of APOL1 and methods of using same
MX2024008868A (es) 2022-01-18 2024-09-23 Maze Therapeutics Inc Inhibidores de la apolipoproteína l1 (apol1) y métodos de uso.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2020414A1 (en) * 2007-06-20 2009-02-04 Laboratorios del Dr. Esteve S.A. spiro[piperidine-4,4'-thieno[3,2-c]pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis
HUP2200468A1 (hu) * 2020-04-29 2023-03-28 X Chem Zrt IAP antagonisták és gyógyászati alkalmazásuk
US20230014907A1 (en) * 2020-06-12 2023-01-19 Vertex Pharmaceuticals Incorporated Inhibitors of apol1 and methods of using same

Similar Documents

Publication Publication Date Title
JP2025505200A5 (cg-RX-API-DMAC7.html)
JP2023539194A5 (cg-RX-API-DMAC7.html)
US6833378B2 (en) Corticotropin releasing factor antagonists
JP2024544060A5 (cg-RX-API-DMAC7.html)
EP3653620B9 (en) New heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 and 2 (hdac1-2)
JP5144670B2 (ja) 2−フェニル−6−アミノカルボニル−ピリミジン誘導体及びp2y12受容体拮抗剤としてのそれらの使用
RU2014131065A (ru) Димерные соединения-агонисты рецептора fgf ( fgfr ), способ их получения и их терапевтическое применение
TW201113267A (en) Quinazolines as potassium ion channel inhibitors
JP2025505647A5 (cg-RX-API-DMAC7.html)
EA020885B1 (ru) Ингибиторы протеинкиназы и их применение
US10947225B2 (en) Phosphotidylinositol 3-kinase inhibitors
JP2019527724A5 (cg-RX-API-DMAC7.html)
EP2139889B1 (en) Amino-naphthyridine derivatives
JP2024543934A5 (cg-RX-API-DMAC7.html)
EP2024335A1 (fr) Nouveaux derives d'imidazoles, leur preparation et leur utilisation en tant que medicament
JP2010510216A5 (cg-RX-API-DMAC7.html)
CN106748892B (zh) 靶向自噬激动剂及其在神经退行性疾病治疗药物中的应用
CA2486872A1 (en) Nf-kb inhibitors and uses thereof
RU2009103302A (ru) Применение производных имидазо[1,2-а]пиридин-2-корбоксамидов в терапии
WO2026008073A1 (zh) 补体因子b抑制剂的剂量组合物
JPH06501690A (ja) 抗ウイルス薬としてのチアゾロイソインドリノン誘導体の使用
WO2014079398A1 (zh) 抗hiv的化合物及其制备方法和用途
KR20140123513A (ko) 탄소환 뉴클레오시드 및 이들의 약학적 용도 및 조성물
US6743795B1 (en) 3-nitropyridine derivaives and the pharmaceutical compositions containing said derivatives
JPWO2022270487A5 (cg-RX-API-DMAC7.html)